Literature DB >> 8125487

Machado Joseph disease is not an allele of the spinocerebellar ataxia 2 locus.

E C Twist1, L A Farrer, P M Macleod, J Radvany, S Chamberlain, R N Rosenberg, G A Rouleau.   

Abstract

Machado Joseph disease (MJD) is a progressive, spinocerebellar ataxia (SCA) with an autosomal dominant mode of inheritance and almost complete penetrance. Clinically, it is difficult to distinguish it from other autosomal dominantly inherited ataxias, and it has been suggested that MJD may be caused by an allelic variant of SCA. Exclusion of MJD from the SCA1 locus on chromosome 6p has previously been demonstrated. However, following the recent assignment of a second locus for spinocerebellar ataxia (SCA2) to chromosome 12q in a large Cuban kindred of Spanish origin, we have investigated linkage in MJD families using the two markers, D12S58 and PLA2, that flank this disease gene. The MJD locus was definitively excluded from an interval spanning approximately 70 cM, which includes these loci. These studies demonstrate that MJD and SCA2 are genetically distinct despite similarities in disease phenotype and ancestral origins of the patients. Thus, the as yet unmapped MJD locus represents a third SCA locus, providing further evidence for genetic heterogeneity within these disorders.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8125487     DOI: 10.1007/bf00212034

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  25 in total

1.  Azorean disease of the nervous system.

Authors: 
Journal:  N Engl J Med       Date:  1977-09-29       Impact factor: 91.245

2.  Azorean disease of the nervous system.

Authors:  F C Romanul; H L Fowler; J Radvany; R G Feldman; M Feingold
Journal:  N Engl J Med       Date:  1977-06-30       Impact factor: 91.245

3.  Ataxia in families from the Azores.

Authors:  D M Dawson
Journal:  N Engl J Med       Date:  1977-06-30       Impact factor: 91.245

4.  Machado-Joseph disease: linkage analysis between the loci for the disease and 18 protein markers.

Authors:  S M Myers; P M MacLeod; R A Forse; C J Forster-Gibson; N E Simpson
Journal:  Cytogenet Cell Genet       Date:  1986

5.  Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies.

Authors:  J Ott
Journal:  Am J Hum Genet       Date:  1974-09       Impact factor: 11.025

6.  Joseph disease in a non-Portuguese family.

Authors:  T Sakai; M Ohta; H Ishino
Journal:  Neurology       Date:  1983-01       Impact factor: 9.910

7.  Machado-Joseph disease of Azorean ancestry in Brazil: the Catarina kindred. Neurological, neuroimaging, psychiatric and neuropsychological findings in the largest known family, the "Catarina" kindred.

Authors:  J Radvany; C H Camargo; Z M Costa; N C Fonseca; E D Nascimento
Journal:  Arq Neuropsiquiatr       Date:  1993-03       Impact factor: 1.420

8.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  The natural history of Machado-Joseph disease. An analysis of 138 personally examined cases.

Authors:  A Barbeau; M Roy; L Cunha; A N de Vincente; R N Rosenberg; W L Nyhan; P L MacLeod; G Chazot; L B Langston; D M Dawson
Journal:  Can J Neurol Sci       Date:  1984-11       Impact factor: 2.104

10.  Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease.

Authors:  R S Kandt; J L Haines; M Smith; H Northrup; R J Gardner; M P Short; K Dumars; E S Roach; S Steingold; S Wall
Journal:  Nat Genet       Date:  1992-09       Impact factor: 38.330

View more
  1 in total

1.  Machado Joseph disease maps to the same region of chromosome 14 as the spinocerebellar ataxia type 3 locus.

Authors:  E C Twist; L K Casaubon; M H Ruttledge; V S Rao; P M Macleod; J Radvany; Z Zhao; R N Rosenberg; L A Farrer; G A Rouleau
Journal:  J Med Genet       Date:  1995-01       Impact factor: 6.318

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.